Trial intelligence / Profile preview

Bivalirudin vs Heparin in High Bleeding Risk PCI (NAPLES III)

NCT01465503Phase 3Completed

Sponsor
Clinica Mediterranea
Start
Jan 2008
Primary completion
Dec 2012
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bivalirudin in hemorrhage, sponsored by Clinica Mediterranea. Started Jan 2008; status: completed.

02

Drugs

bivalirudin
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT01465503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01465503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call